Download Now: 7 Unstoppable Growth Engines of India's $10 Trillion Bull Run...
Here is the latest financial fact sheet of KREBS BIOCHEMICALS. For more details, see the KREBS BIOCHEMICALS quarterly results and KREBS BIOCHEMICALS share price. For a sector overview, read our pharmaceuticals sector report.
1 Day | % | 2.6 |
No. of shares | m | 21.56 |
1 Week | % | 1.5 |
1 Month | % | 9.8 |
1 Year | % | 1.5 |
52 week H/L | Rs | 93.2/59.3 |
No. of Mths Year Ending |
12 Mar-19* |
12 Mar-20* |
12 Mar-21* |
12 Mar-22* |
12 Mar-23* |
5-Yr Chart Click to enlarge
|
---|
KREBS BIOCHEMICALS EQUITY SHARE DATA | |||||||
---|---|---|---|---|---|---|---|
High | Rs | 200 | 118 | 148 | 228 | 190 | |
Low | Rs | 85 | 60 | 60 | 83 | 51 | |
Sales per share (Unadj.) | Rs | 28.7 | 18.6 | 27.4 | 27.7 | 24.2 | |
Earnings per share (Unadj.) | Rs | -12.0 | -16.0 | -14.5 | -20.7 | -11.5 | |
Diluted earnings per share | Rs | -9.3 | -13.4 | -13.2 | -20.7 | -11.5 | |
Cash flow per share (Unadj.) | Rs | -9.4 | -13.4 | -11.8 | -17.7 | -8.4 | |
Dividends per share (Unadj.) | Rs | 0 | 0 | 0 | 0 | 0 | |
Adj. dividends per share | Rs | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Avg Dividend yield | % | 0 | 0 | 0 | 0 | 0 | |
Book value per share (Unadj.) | Rs | -8.6 | -18.1 | -23.9 | -34.8 | -46.1 | |
Adj. book value per share | Rs | -6.6 | -15.1 | -21.8 | -34.8 | -46.1 | |
Shares outstanding (eoy) | m | 16.63 | 18.00 | 19.62 | 21.56 | 21.56 | |
Price / Sales ratio | x | 5.0 | 4.8 | 3.8 | 5.6 | 5.0 | |
Avg P/E ratio | x | -11.8 | -5.5 | -7.2 | -7.5 | -10.5 | |
P/CF ratio (eoy) | x | -15.2 | -6.6 | -8.8 | -8.8 | -14.3 | |
Price / Book Value ratio | x | -16.6 | -4.9 | -4.3 | -4.5 | -2.6 | |
Dividend payout | % | 0 | 0 | 0 | 0 | 0 | |
Avg Mkt Cap | Rs m | 2,371 | 1,602 | 2,039 | 3,347 | 2,599 | |
Total wages/salary | Rs m | 144 | 146 | 153 | 150 | 155 |
KREBS BIOCHEMICALS INCOME DATA | |||||||
---|---|---|---|---|---|---|---|
Net Sales | Rs m | 478 | 334 | 537 | 597 | 521 | |
Other income | Rs m | 3 | 4 | 6 | 12 | 6 | |
Total revenues | Rs m | 481 | 338 | 543 | 609 | 528 | |
Gross profit | Rs m | -97 | -186 | -176 | -340 | -158 | |
Depreciation | Rs m | 44 | 47 | 51 | 63 | 66 | |
Interest | Rs m | 63 | 60 | 63 | 54 | 30 | |
Profit before tax | Rs m | -200 | -289 | -284 | -445 | -247 | |
Minority Interest | Rs m | 0 | 0 | 0 | 0 | 0 | |
Prior Period Items | Rs m | 0 | 0 | 0 | 0 | 0 | |
Extraordinary Inc (Exp) | Rs m | 0 | 0 | 0 | 0 | 0 | |
Tax | Rs m | 0 | 0 | 0 | 0 | 0 | |
Profit after tax | Rs m | -200 | -289 | -284 | -445 | -247 | |
Gross profit margin | % | -20.2 | -55.5 | -32.7 | -56.9 | -30.3 | |
Effective tax rate | % | 0 | 0 | 0 | 0 | 0 | |
Net profit margin | % | -41.9 | -86.4 | -52.8 | -74.6 | -47.4 |
KREBS BIOCHEMICALS BALANCE SHEET DATA | |||||||
---|---|---|---|---|---|---|---|
Current assets | Rs m | 310 | 189 | 214 | 355 | 161 | |
Current liabilities | Rs m | 549 | 431 | 482 | 781 | 491 | |
Net working cap to sales | % | -50.0 | -72.6 | -49.9 | -71.3 | -63.4 | |
Current ratio | x | 0.6 | 0.4 | 0.4 | 0.5 | 0.3 | |
Inventory Days | Days | 51 | 60 | 54 | 44 | 53 | |
Debtors Days | Days | 222 | 22 | 20 | 54 | 37 | |
Net fixed assets | Rs m | 1,114 | 1,149 | 1,378 | 1,543 | 1,589 | |
Share capital | Rs m | 166 | 180 | 196 | 216 | 216 | |
"Free" reserves | Rs m | -309 | -507 | -665 | -967 | -1,210 | |
Net worth | Rs m | -143 | -327 | -469 | -751 | -995 | |
Long term debt | Rs m | 502 | 655 | 1,005 | 1,329 | 1,732 | |
Total assets | Rs m | 1,424 | 1,338 | 1,592 | 1,898 | 1,750 | |
Interest coverage | x | -2.2 | -3.8 | -3.5 | -7.3 | -7.3 | |
Debt to equity ratio | x | -3.5 | -2.0 | -2.1 | -1.8 | -1.7 | |
Sales to assets ratio | x | 0.3 | 0.2 | 0.3 | 0.3 | 0.3 | |
Return on assets | % | -9.6 | -17.1 | -13.9 | -20.6 | -12.4 | |
Return on equity | % | 140.0 | 88.4 | 60.5 | 59.3 | 24.8 | |
Return on capital | % | -38.2 | -69.6 | -41.2 | -67.7 | -29.4 | |
Exports to sales | % | 0 | 0 | 0 | 0 | 0 | |
Imports to sales | % | 0 | 0 | 0 | 0 | 0 | |
Exports (fob) | Rs m | 0 | 0 | 0 | 0 | 0 | |
Imports (cif) | Rs m | 0 | 0 | 0 | 0 | 0 | |
Fx inflow | Rs m | 4 | 0 | 0 | 0 | 0 | |
Fx outflow | Rs m | 8 | 8 | 21 | 12 | 5 | |
Net fx | Rs m | -3 | -8 | -21 | -12 | -5 |
KREBS BIOCHEMICALS CASH FLOW | |||||||
---|---|---|---|---|---|---|---|
From Operations | Rs m | 39 | -355 | -146 | -172 | -247 | |
From Investments | Rs m | -43 | -102 | -225 | -229 | -126 | |
From Financial Activity | Rs m | 173 | 286 | 377 | 395 | 373 | |
Net Cashflow | Rs m | 169 | -171 | 5 | -6 | -0 |
Share Holding
Shareholding as on Mar 2024
|
Company Information
|
CHM: R T Ravi | COMP SEC: Keyur Doshi | YEAR OF INC: 1991 | BSE CODE: 524518 | FV (Rs): 10 | DIV YIELD (%): - |
More Pharmaceuticals Company Fact Sheets: DIVIS LABORATORIES DR. REDDYS LAB ZYDUS LIFESCIENCES CIPLA SUN PHARMA
Compare KREBS BIOCHEMICALS With: DIVIS LABORATORIES DR. REDDYS LAB ZYDUS LIFESCIENCES CIPLA SUN PHARMA
After opening the day on high, Indian share markets reversed the trend as the session progressed and ended the lower.